Literature DB >> 21813674

Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses.

Lucia Tapia1, Austen Milnerwood, Aobo Guo, Fergil Mills, Eileen Yoshida, Cristina Vasuta, Ian R Mackenzie, Lynn Raymond, Max Cynader, William Jia, Shernaz X Bamji.   

Abstract

Frontotemporal dementia (FTD) has been linked to mutations in the progranulin gene (GRN) that lead to progranulin (PGRN) haploinsufficiency. Thus far, our understanding of the effects of PGRN depletion in the brain has been derived from investigation of gross pathology, and more detailed analyses of cellular function have been lacking. We report that knocking down PGRN levels in rat primary hippocampal cultures reduces neural connectivity by decreasing neuronal arborization and length as well as synapse density. Despite this, the number of synaptic vesicles per synapse and the frequency of mEPSCs are increased in PGRN knockdown cells, suggesting an increase in the probability of release at remaining synapses. Interestingly, we demonstrate that the number of vesicles per synapse is also increased in postmortem brain sections from FTD patients with PGRN haploinsufficiency, relative to controls. Our observations show that PGRN knockdown severely alters neuronal connectivity in vitro and that the synaptic vesicle phenotype observed in culture is consistent with that observed in the hippocampus of FTD patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813674      PMCID: PMC6623368          DOI: 10.1523/JNEUROSCI.6244-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

Review 1.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

2.  Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers.

Authors:  Nikolas R Block; Sharon J Sha; Anna M Karydas; Jamie C Fong; Mary G De May; Bruce L Miller; Howard J Rosen
Journal:  Am J Geriatr Psychiatry       Date:  2015-06-21       Impact factor: 4.105

3.  FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.

Authors:  Qinwen Mao; Xiaojing Zheng; Tamar Gefen; Emily Rogalski; Callen L Spencer; Rosa Rademakers; Angela J Fought; Missia Kohler; Sandra Weintraub; Haibin Xia; Marek-Marsel Mesulam; Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2019-09-01       Impact factor: 3.685

4.  The Progranulin Cleavage Products, Granulins, Exacerbate TDP-43 Toxicity and Increase TDP-43 Levels.

Authors:  Dominique A Salazar; Victoria J Butler; Andrea R Argouarch; Tsung-Yuan Hsu; Amanda Mason; Ayumi Nakamura; Helen McCurdy; David Cox; Rachel Ng; Gloria Pan; William W Seeley; Bruce L Miller; Aimee W Kao
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

Review 5.  Diagnosis and management of behavioral variant frontotemporal dementia.

Authors:  Peter S Pressman; Bruce L Miller
Journal:  Biol Psychiatry       Date:  2013-11-13       Impact factor: 13.382

6.  Circulating progranulin as a biomarker for neurodegenerative diseases.

Authors:  Roberta Ghidoni; Anna Paterlini; Luisa Benussi
Journal:  Am J Neurodegener Dis       Date:  2012-08-02

Review 7.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

8.  Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects.

Authors:  Sandra Almeida; Zhijun Zhang; Giovanni Coppola; Wenjie Mao; Kensuke Futai; Anna Karydas; Michael D Geschwind; M Carmela Tartaglia; Fuying Gao; Davide Gianni; Miguel Sena-Esteves; Daniel H Geschwind; Bruce L Miller; Robert V Farese; Fen-Biao Gao
Journal:  Cell Rep       Date:  2012-10-11       Impact factor: 9.423

Review 9.  Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.

Authors:  Adam L Boxer; Michael Gold; Edward Huey; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven Khachaturian; Margaret Sutherland; Robert Farese; Bruce L Miller; Jeffrey Cummings
Journal:  Alzheimers Dement       Date:  2012-10-05       Impact factor: 21.566

Review 10.  The Role of PGRN in Alzheimer's Disease.

Authors:  Hua Jing; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.